The above findings, collectively, may suggest that feedback activation of AKT is a common theme among breast and other cancers addicted to EGFR/HER2 and/or displaying over-activation of ERK signalling[26,27,31], this however, is not the case. The gene discussed is ERBB2; the disease is cancer.